CDC Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in U.S.

Published: 12/31/2020

Sources:
  • Centers for Disease Control and Prevention
Relevant To:
  • All Healthcare Organizations

The U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has issued interim recommendations for the use of Pfizer-BioNTech and Moderna COVID-19 vaccines for the prevention of coronavirus disease 2019 (COVID-19) in the United States. Both vaccines are lipid nanoparticle-formulated, nucleoside-modified mRNA vaccines encoding the prefusion spike glycoprotein of SARS-CoV-2, the virus that causes COVID-19.

These interim CDC clinical considerat

Sign Up for Free Trial